Arctic Vision
PrivateLast Round
Series B
Mar 9, 2021
Total Funding Raised
$132M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arctic Vision is a biotechnology company that develops and commercializes innovative ophthalmic therapies and medical devices for retinal diseases, dry eye, and ocular neuroprotection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arctic Vision Comparables
Compare Arctic Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AffaMed Therapeutics | 90% | |
| Eluminex Biosciences | 84% | |
| Ocumension Therapeutics | 82% |
Arctic Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 9, 2021 | ||||
| Series A | Jul 13, 2020 | ||||
| Seed | May 1, 2019 |
Key People
Founding team and executive leadership
Arctic Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series B |
| Morningside Ventures | Series B, Series A |
| Nan Fung Life Sciences | Series B, Series A, Seed |
| Nan Fung Group | Series B, Series A |
| Octagon Capital Advisors | Series B |
| Octagon Capital | Series B |
| Pivotal bioVenture Partners China | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 66% MoM.
- Jan 17, 2025
Attended Hurun Global Gazelles 2024 and received an award.
Arctic Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arctic Vision's valuation, stock price, and market status.
Is Arctic Vision a public or private company?
Arctic Vision is a private company.
What is the current stock price of Arctic Vision?
Arctic Vision is a private company with no public stock price. No recent secondary market data is available.
How much is Arctic Vision worth (valuation)?
Valuation information for Arctic Vision is not publicly available.
Can I buy Arctic Vision stock?
Arctic Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arctic Vision's last funding round?
Arctic Vision's most recent funding round was Series B on March 9, 2021.
Who are the main investors in Arctic Vision?
Key investors in Arctic Vision include Loyal Valley Capital, Morningside Ventures, Nan Fung Life Sciences, Pivotal bioVenture Partners China.
Will Arctic Vision IPO soon?
No public IPO plans have been announced for Arctic Vision.
How can I track Arctic Vision secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arctic Vision's secondary market activity and sign up for updates.